DOUGLAS E. WILLIAMS - 10 Apr 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP & President, R&D
Signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Douglas E. Williams
Issuer symbol
SANA
Transactions as of
10 Apr 2023
Net transactions value
$0
Form type
4
Filing time
11 Apr 2023, 16:26:28 UTC
Previous filing
30 Mar 2023
Next filing
03 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Award $0 +1,100,000 $0.000000 1,100,000 10 Apr 2023 Common Stock 1,100,000 $3.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on April 10, 2024 and in 36 equal monthly installments thereafter.